Klava Innovation
KLAVA Innovation is a DeepTech/Medtech startup focused on developing accessible, evidence-based treatments for addictive disorders, with an initial focus on tobacco cessation. Their flagship product, Quitoxil®, is a Class I medical device and the first digital therapeutic for addiction to be distributed in French pharmacies. Quitoxil® is based on validated cognitive behavioral therapies (CBT) and offers personalized support, patient monitoring, and a platform for healthcare professionals. The company collaborates with leading research institutions like the AP-HP Paul Brousse and has achieved significant user engagement, with 987 patients included and 81.75% engagement over 30 days. KLAVA aims to improve access to care and plans to expand its offerings to other addictive disorders.
Klava Innovation
KLAVA Innovation is a DeepTech/Medtech startup focused on developing accessible, evidence-based treatments for addictive disorders, with an initial focus on tobacco cessation. Their flagship product, Quitoxil®, is a Class I medical device and the first digital therapeutic for addiction to be distributed in French pharmacies. Quitoxil® is based on validated cognitive behavioral therapies (CBT) and offers personalized support, patient monitoring, and a platform for healthcare professionals. The company collaborates with leading research institutions like the AP-HP Paul Brousse and has achieved significant user engagement, with 987 patients included and 81.75% engagement over 30 days. KLAVA aims to improve access to care and plans to expand its offerings to other addictive disorders.
TL;DR
Headquarters: Boulogne-Billancourt / Paris, France
Founded: 2021
Lead product: Quitoxil® — digital therapeutic (Class I medical device) for smoking cessation
Employees: 15
Seed round: Announced Jan 29, 2024; lead investor: Angels’ Bay Invest
Company Overview
Problem Domain
Treatment of addictive disorders, initial focus on tobacco/smoking cessation
Founded
2021
Industry
DeepTech / MedTech; digital therapeutics for addiction
Funding Track Record
Investor Signal
“Angels’ Bay Invest led the Seed round announced Jan 29, 2024”